Next report date
Report period
Q2 2024
EPS estimate
—
Revenue estimate
—
−0.82CNY
−328.96 MCNY
111.08 MCNY
289.85 M
About FRONTIER BIOTECHNOLOGIES INC.
Sector
Industry
CEO
Chang Jin Wang
Website
Headquarters
Nanjing
Employees (FY)
395
Founded
2013
ISIN
CNE100005XF5
FIGI
BBG00PZ7WBM6
Frontier Biotechnologies, Inc. engages in the research and development, production, and sale of medicines. Its offers include anti-human immunodeficiency virus treatment and pain treatment. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688221 is 6.35 CNY — it has increased by 4.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange FRONTIER BIOTECHNOLOGIES INC. stocks are traded under the ticker 688221.
FRONTIER BIOTECHNOLOGIES INC. is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
688221 stock is 4.26% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is FRONTIER BIOTECHNOLOGIES INC. there?
688221 earnings for the last quarter are −0.38 CNY per share, whereas the estimation was −0.37 CNY resulting in a −4.75% surprise. The estimated earnings for the next quarter are −0.17 CNY per share. See more details about FRONTIER BIOTECHNOLOGIES INC. earnings.
FRONTIER BIOTECHNOLOGIES INC. revenue for the last quarter amounts to 35.69 M CNY despite the estimated figure of 41.22 M CNY. In the next quarter revenue is expected to reach 36.44 M CNY.
Yes, you can track FRONTIER BIOTECHNOLOGIES INC. financials in yearly and quarterly reports right on TradingView.
688221 stock has risen by 13.60% compared to the previous week, the month change is a 7.16% fall, over the last year FRONTIER BIOTECHNOLOGIES INC. has showed a 50.04% decrease.
688221 net income for the last quarter is −55.71 M CNY, while the quarter before that showed −86.50 M CNY of net income which accounts for 35.60% change. Track more FRONTIER BIOTECHNOLOGIES INC. financial stats to get the full picture.
Today FRONTIER BIOTECHNOLOGIES INC. has the market capitalization of 2.28 B, it has increased by 2.94% over the last week.
No, 688221 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 688221 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRONTIER BIOTECHNOLOGIES INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 395.00 employees. See our rating of the largest employees — is FRONTIER BIOTECHNOLOGIES INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRONTIER BIOTECHNOLOGIES INC. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRONTIER BIOTECHNOLOGIES INC. stock shows the sell signal. See more of FRONTIER BIOTECHNOLOGIES INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.